Valorisations sectorielles Neurocrine Biosciences, Inc.
Actions
NBIX
US64125C1099
Produits pharmaceutiques
|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 174,26 USD | +3,87% |
|
+3,41% | +22,87% |
Principaux concurrents
Ajouter à une liste 0 sélectionné | PER (Y) | Price to Book (Y) | PEG (Y) | VE / CA (Y) | VE / EBITDA (Y) | VE / EBIT (Y) | Rendement du dividende (Y) | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|
 | 32.12x | 4.54x | 1.98x | 4.5x | 16.49x | 27.64x | -.--% | 17,52 Md | |
| 35.49x | 21.37x | 0.72x | 12.89x | 26.26x | 27.07x | 0,56% | 1 082 Md | |
| 28.11x | 7.08x | -1.85x | 6.46x | 17.57x | 19.38x | 2,03% | 633 Md | |
| 32.2x | 999.69x | 0.13x | 7.69x | 15.73x | 16.14x | 2,65% | 461 Md | |
| 18.15x | 6.74x | 1.07x | 4.51x | 11.08x | 12.5x | 2,94% | 338 Md | |
| 24.06x | 5.64x | 1.06x | 5.03x | 14.1x | 15.02x | 1,73% | 299 Md | |
| 22.19x | 6.64x | -48.62x | 5.69x | 13.74x | 15.05x | 2,76% | 291 Md | |
| 14.43x | 6.33x | -8.88x | 5.37x | 11.03x | 12.94x | 3,47% | 222 Md | |
| 24.39x | 18.58x | 3.12x | 6.45x | 11.36x | 14.77x | 2,7% | 202 Md | |
| -46.87x | 8.32x | 0.33x | 5.66x | 31.47x | 63.22x | 2,47% | 163 Md | |
| 11.37x | 1.58x | 0.2x | 3.03x | 7.37x | 8.58x | 7,2% | 139 Md | |
| 30.19x | 6.06x | 2.13x | 9.3x | 20.97x | 21.83x | -.--% | 134 Md | |
| 12.95x | 4.65x | 1.26x | 2.81x | 8.24x | 9.34x | 3,47% | 107 Md | |
| 11.35x | 1.21x | 2.62x | 2.14x | 6.87x | 7.84x | 5,61% | 104 Md | |
| 24.73x | 5.6x | 1.44x | 8.4x | 15.9x | 16.63x | 1,79% | 77,98 Md | |
| 23.01x | 1.87x | -0.14x | 1.85x | 8.76x | 14.7x | 0,43% | 59,97 Md | |
| 38.7x | 5.23x | 2.01x | 8.73x | 29.13x | 32.08x | 0,5% | 53,01 Md | |
| 43.57x | 1.15x | 53.26x | 2.67x | 9.81x | 27.17x | 3,81% | 52,5 Md | |
| 18.81x | 1.9x | 4.01x | 3.42x | 12.85x | 14.42x | 2,19% | 42,89 Md | |
| Moyenne | 21,00x | 58,64x | 0,84x | 5,61x | 15,20x | 19,81x | 2,44% | 235,8 Md | |
| Moyenne pondérée par Capi. | 24,23x | 112,46x | -2,49x | 7,47x | 17,57x | 20,23x | 2,14% |
- Bourse
- Actions
- Action NBIX
- Secteur Neurocrine Biosciences, Inc.
- Valorisations sectorielles
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
